GLP1 Periconception Exposure and OB Outcomes
From Dr. Chapa’s OBGYN Clinical Pearls by Dr. Chapa’s Clinical Pearls
May 4, 2026 · 22 min
About this episode
This episode discusses the implications of GLP1 periconception exposure on obstetric outcomes, summarizing recent systematic reviews and studies.
There is no denying it, you know of one or MORE individuals or patients currently on a GLP1 agent. Although not FDA approved for PCOS as a stand-alone diagnosis, there is growing evidence supporting their offlabel use in PCOS, and international guidelines now include them as a conditional recommendation. In women, the weight loss associated with these medications may trigger the return of spontaneous ovulation, making mistimed pregnancy a possibility. A key study by Sanz and Blázquez (back in 2011) demonstrated that both GLP-1 and the GLP-1 receptor are present in mouse embryos as early as embryonic day 6 (E6) and continue through the first trimester, as well as in pluripotent mouse embryonic stem cells. In these undifferentiated cells, GLP-1 modified the expression of endodermal, ectodermal, and mesodermal gene markers, as well as critical developmental signaling molecules. So, there is a concern about embryogenesis if inadvertent exposure to these meds occurs in early pregnancy. In this episode, we will summarize 2 recent and separate systematic reviews (March 2026; April 2026) on fetal/OB outcomes after periconceptional exposure. This builds on the Parker data set from 2025…
People in this episode
Host: Dr. Chapa
Topics covered
- GLP1
- periconception exposure
- obstetric outcomes
- PCOS
- embryogenesis
- systematic reviews
- meta-analysis
Keywords
- GLP1
- PCOS
- embryogenesis
- obstetric outcomes
- systematic review
- meta-analysis
- weight loss
- spontaneous ovulation
- fetal safety
Mentioned in this episode
Organizations: Sanz and Blázquez, Parker, Ozbek L, Shah E, Al-Shiab R, Inal A, Guldan M, Afsar B, Covic A, Kanbay M
Products: GLP1, GLP-1 receptor
More episodes of Dr. Chapa’s OBGYN Clinical Pearls
- 2026 Lp(a), AHA, and OBG: What Now? · June 12, 2026 · 27 min
- CS: UT in or UT out? New July 2026 Data · June 10, 2026 · 15 min
- SHOCKING: ACSs INCREASE Risk in Twins? (Listen in) · June 8, 2026 · 16 min
- 5mm v 1-cm Fascial Closure at CS: MINI EPISODE · June 6, 2026 · 3 min
- NIPT CONFIRM Test SPECIAL GUEST: Blurring the Line between Screening & Confirmation of Fetal Aneuploidy · June 5, 2026 · 23 min
- OB, ED, and STDs: Gaps Noted! · June 3, 2026 · 14 min
Explore listener stats, chart rankings, contacts and more on the Dr. Chapa’s OBGYN Clinical Pearls podcast page.